FF
Florian Fischer at Affimed Therapeutics (NAS: AFMD)
Developer of unique TandAb antibody therapeutics for cancer and inflammatory diseases
ContactFirm
Affimed Therapeutics (NAS: AFMD)
Location
Global
Investment Stage
Growth
Geographic Focus
Global
About Florian Fischer
Enriching content...
Similar Investors in Global
Contact Affimed Therapeutics (NAS: AFMD)
Get in touch for investment criteria and partnership opportunities.
Contact